Related Experiment Video
Updated: May 2, 2026
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Borderline ovarian tumors: a study of 100 cases from a Tertiary Care Hospital
Ahmet Uysal1, Semih Mun2, Fatma Uysal3
1Ministry of Health, Aegean Maternity and Teaching Hospital, Department of Obstetrics and Gynecology, Izmir, Turkey ; Çanakkale Onsekiz Mart University Faculty of Medicine, Department of Obstetrics and Gynecology, Çanakkale, Turkey.
Aim Of The Study:
The purpose of the study was to evaluate patients with borderline ovarian tumors.
Material And Methods:
Clinical features, treatment and survival status of 100 patients with borderline ovarian tumors were retrospectively evaluated between 1998 and 2007.
Results:
Patients' mean age was 37.75 years (range: 15-72); 22 of them were postmenopausal. Histopathological diagnoses were serous, mucinous, endometrioid and clear cell in 54%, 41%, 2% and 3% of the patients, respectively; 70 patients had stage IA disease, 8 were at stage IB, 16 at stage IC, 2 at stage IIIA, 3 at stage IIIB and 1 at stage IIIC. Restaging laparotomies were performed on 19 patients; fertility-sparing surgery was performed on 52 patients; 2 patients received chemotherapy because of advanced-stage disease. All patients are currently alive. The 5-year disease-free survival rate for 71 cases was 100%.
Conclusions:
Borderline ovarian tumors have excellent prognoses, and fertility-conserving surgery can be performed in young patients with early-stage disease.
